Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke
NCT ID: NCT00681707
Last Updated: 2009-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2008-05-31
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Survey for Patients With Hypertension and Diabetes Mellitus
NCT00681278
Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension
NCT00771069
Feasibility Study of the Intensive Systolic Blood Pressure Control
NCT02817503
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
NCT01703780
Observational Study to Investigate Resistant Hypertension Prevalence in Korean General Hospitals
NCT01753206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Hypertension patients recovering from stroke
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with history of stroke receiving hypertension medication during at least 1 year.
Exclusion Criteria
* Patients not receiving hypertension medication
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joon Woo Bahn
Role: STUDY_DIRECTOR
Astrazenca Korea medical dept.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Wŏnju, Gangwon-do, South Korea
Research Site
Goyang-si, Gyeonggi-do, South Korea
Research Site
Sungnam, Gyeonggi-do, South Korea
Research Site
Busan, , South Korea
Research Site
Deagu, , South Korea
Research Site
Deajeon, , South Korea
Research Site
Kwangju, , South Korea
Research Site
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CKR-DUM-2008/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.